– Late-breaking Phase III results show subcutaneous injection was non-inferior to intravenous infusion based on Ocrevus levels in the blood over 12 weeks – – Ocrevus subcutaneous injection was ...
Newly opened IV therapy service Essence of Thirst is geared up to help the community make a fresh start for 2026.
BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that they have submitted a proposed Marketing Authorisation Variation to the European Medicines Agency (EMA) for a once ...
DENVER — Administering multiple intravenous (IV) infusions is common in the critical care environment, but it increases the potential for errors. Researchers with the HumanEra project at University ...
Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study Patients with ≥1 prior line of therapy were ...
Rituxan (rituximab) is a prescription drug used to treat certain cancers, rheumatoid arthritis (RA), and other conditions. Rituxan comes as an intravenous (IV) infusion. Rituxan is a type of ...
Engage: A Survivorship Program to Improve Childhood Cancer Survivors' Self-Efficacy and Quality of Life The development of subcutaneous (SC) formulations for monoclonal antibodies (mAbs), as an ...
The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the Biologics License Application (BLA) for Saphnelo (anifrolumab) for subcutaneous administration in ...
This is one of those friend-of-a-friend tales, so it’s a bit short on details. But the basic story is this: A young and generally healthy man was feeling run down, so he went to a wellness spa to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results